CN103432045B - Body-building and slimming composition and body-building and slimming cream - Google Patents
Body-building and slimming composition and body-building and slimming cream Download PDFInfo
- Publication number
- CN103432045B CN103432045B CN201310404808.1A CN201310404808A CN103432045B CN 103432045 B CN103432045 B CN 103432045B CN 201310404808 A CN201310404808 A CN 201310404808A CN 103432045 B CN103432045 B CN 103432045B
- Authority
- CN
- China
- Prior art keywords
- component
- building
- reducing
- building weight
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 239000006071 cream Substances 0.000 title abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 61
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 40
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims abstract description 20
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960001948 caffeine Drugs 0.000 claims abstract description 20
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960004203 carnitine Drugs 0.000 claims abstract description 20
- 235000005320 Coleus barbatus Nutrition 0.000 claims abstract description 19
- 241000131459 Plectranthus barbatus Species 0.000 claims abstract description 19
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 14
- 229960004756 ethanol Drugs 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000000787 lecithin Substances 0.000 claims description 18
- 229940067606 lecithin Drugs 0.000 claims description 18
- 235000010445 lecithin Nutrition 0.000 claims description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 12
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- -1 polydimethylsiloxane Polymers 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 6
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 6
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 6
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 6
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 6
- 229960000735 docosanol Drugs 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000011630 iodine Substances 0.000 claims description 6
- KRPAJLYSLFNDOA-UHFFFAOYSA-N mephenesin carbamate Chemical compound CC1=CC=CC=C1OCC(O)COC(N)=O KRPAJLYSLFNDOA-UHFFFAOYSA-N 0.000 claims description 6
- 229950006838 mephenesin carbamate Drugs 0.000 claims description 6
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 235000010384 tocopherol Nutrition 0.000 claims description 6
- 229960001295 tocopherol Drugs 0.000 claims description 6
- 229930003799 tocopherol Natural products 0.000 claims description 6
- 239000011732 tocopherol Substances 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 16
- 210000004003 subcutaneous fat Anatomy 0.000 abstract description 5
- 102000008186 Collagen Human genes 0.000 abstract description 4
- 108010035532 Collagen Proteins 0.000 abstract description 4
- 230000008685 targeting Effects 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 102000016942 Elastin Human genes 0.000 abstract description 3
- 108010014258 Elastin Proteins 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 229920001436 collagen Polymers 0.000 abstract description 3
- 229920002549 elastin Polymers 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 210000002808 connective tissue Anatomy 0.000 abstract description 2
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000001737 promoting effect Effects 0.000 abstract 2
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 229940059958 centella asiatica extract Drugs 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 description 21
- 238000012360 testing method Methods 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 239000013521 mastic Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 206010033307 Overweight Diseases 0.000 description 7
- 210000001789 adipocyte Anatomy 0.000 description 7
- 206010033675 panniculitis Diseases 0.000 description 7
- 210000004304 subcutaneous tissue Anatomy 0.000 description 7
- 241000271566 Aves Species 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- DRCWOKJLSQUJPZ-DZGCQCFKSA-N (4ar,9as)-n-ethyl-1,4,9,9a-tetrahydrofluoren-4a-amine Chemical compound C1C2=CC=CC=C2[C@]2(NCC)[C@H]1CC=CC2 DRCWOKJLSQUJPZ-DZGCQCFKSA-N 0.000 description 4
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 4
- 102100027441 Nucleobindin-2 Human genes 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 229960002743 glutamine Drugs 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 230000002366 lipolytic effect Effects 0.000 description 3
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Abstract
The invention relates to a body-building and slimming composition and body-building and slimming cream. A body-building and slimming compound is added to the body-building and slimming cream; the body-building and slimming compound comprises ovolecithin, ethanol, caffeine, carnitine, centella asiatica extract, phosphate buffer, and coleus forskohlii root extract; and the weight percent of the body-building and slimming compound is 3-8%. The component prepared by using biological science and technology and a plant extraction technology has high safety and good targeting property and has the effects of effectively decomposing fat lobules protruding into a dermal tissue from a connective tissue, promoting metabolism of the skin, promoting a microcirculatory system, stimulating hyperplasia of collagen and elastin, effectively transferring active ingredients to the skin, effectively improving ripples of cellulite, reducing subcutaneous fat, nourishing and moisturizing the skin and the like.
Description
Technical field
The invention belongs to body-building weight-reducing field, specifically relate to a kind of body-building weight-reducing compositions and body-building weight-reducing frost.
Background technology
Worldwide incidence of obesity increases year by year, and WHO has been located as a kind of important disease, and it has become public health problem important in world wide.Fat exist following harm: the danger increasing cardiovascular disease, affects the function of digestive system, affect the function of hormonal system, and increase the danger that cancer occurs, obesity not only affects pretty figure, and makes troubles to life; Joint soft tissue injury, reproductive performance is had to decline and mental maladjustment, heart disease, diabetes, atherosclerosis, fatty liver, cholelithiasis, edema, gout etc. in addition.National survey shows, and within 2002, China adult Overweight and obesity incidence rate is respectively 22.8% and 7.1%.Obesity can cause hypertension, diabetes, coronary heart disease, hyperlipemia, sleep apnea, depression etc., and wherein, for hypertension, overweight people's sickness rate is 25 ~ 55%; For diabetes, overweight people's sickness rate is 14 ~ 20%; For coronary heart disease, overweight people's sickness rate is 10 ~ 15%; For hyperlipemia, overweight people's sickness rate is 35 ~ 53%; For sleep apnea syndrome, overweight people's sickness rate is 10 ~ 20%; For depression, in overweight people, sickness rate is 70 ~ 90%.
Weight reducing frost is the cream kind product of external, to be applied on skin for reducing subcutaneous fat, making the special defects cosmetics for skin of body body-building, containing the material of all kinds of burn fat, skin care, to have good slimming effect.Heredity, fast fat or thin, excessive drinking are stayed up late, sitting is not moved, and when diet is irregular or estrogen increases sharply, all likely causes fat to hoard, not only affect the body body-building of human body, and be detrimental to health.Along with the improvement of society, growth in the living standard, the cream frost that consumer has body-building weight-reducing effect to these is more and more urgent.
At present, as the weight reducing frost of diet products, in order to reach slimming effect, can use some illegal drug adding ingredients in its a lot of formula, safety is constantly under suspicion; In addition, its targeting is poor, after using weight reducing frost, sometimes thinks that thin place is not thin and does not come, and do not think thin place, has thinly got off; Particularly for minimizing subcutaneous fat, improve tangerine hull constitution aspect poor effect.
Summary of the invention
In order to overcome the deficiency that prior art exists, the invention provides a kind of safety, targeting good, effectively reduce subcutaneous fat, improve the body-building weight-reducing compositions of tangerine hull constitution and body-building weight-reducing frost.
A kind of body-building weight-reducing compositions, by weight percentage, comprise following component: lecithin 0.5 ~ 10%, ethanol 1.0 ~ 20%, caffeine 0.05 ~ 2.0%, carnitine 0.05 ~ 2.0%, Herba Centellae extract 0.05 ~ 2.0%, the phosphate buffer 0.05 ~ 2.0% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.05 ~ 2.0%, deionized water 60 ~ 97.75%.
Lecithin is the one group of filemot oil material be present among animal vegetable tissue and yolk, and it can promote the regeneration capacity of Skin Cell, makes skin exquisiteness glossy.
Caffeine is a kind of alkaloid extract from Folium Camelliae sinensis, coffee cherry, and caffeine can improve the speed of human consumption heat, can accelerate steatolysis, helps to eliminate tissue edema, increases microcirculation metabolism.
Carnitine (left-handed Carnitine) is a kind of amino acid, and produce by biotechnology and obtain, it can affect the lipid metabolism of body, can promote fat combustion.
Herba Centellae extract can compact epidermis and corium coupling part, and skin can be made to limber up, and helps to promote that in skin corium, collagen protein is formed, and can reach the effect that skin compacts, can also suppress the increase of adipose cell, eliminates hydroderma.
The phosphate buffer of pH5.7 ~ 8.5 is in the present invention for the stabilizing agent of compositions.Preferably, described phosphate buffer is kaliumphosphate buffer.
Coleus forskohlii Briq. root extract contributes to suppressing health depot fat, can affect the lipid metabolism of body.
A body-building weight-reducing frost, it comprises component A, B component, component C, D component and component E; By total weight percent meter, each component composition and content are:
Component A: lecithin 0.5 ~ 3.0%, Sucrose Polystearic Acid Esters 1.0 ~ 2.5%, Parleam 3.5 ~ 6.5%, behenyl alcohol polyethers-25 0.5 ~ 2.0%, cetearyl alcohol 1.5 ~ 3.5%, C15-19 alkane 2.0 ~ 4.0%, ring five polydimethylsiloxane 0.5 ~ 1.5%, polydimethylsiloxane 0.5 ~ 2.0%, Butyrospermum Parkii Oil 1.0 ~ 3.0%, tocopherol acetas 0.1 ~ 0.5%, butylated hydroxytoluene 0.02 ~ 0.07%;
B component: deionized water 52.25 ~ 80.94%, ethanol 1.0 ~ 5.0%, ethylenediaminetetraacetic acid 0.02 ~ 0.07%, N-acetyl-glucosamine 0.2 ~ 1.0%, glycerol 3.0 ~ 5.0%, butanediol 3.0 ~ 5.0%, carbomer 0.3 ~ 1.0%;
Component C: triethanolamine 0.1 ~ 0.4%;
D component: DMDM Hydantoin 0.05 ~ 0.25%, iodine propilolic alcohol butyl mephenesin Carbamate 0.01 ~ 0.03%, caffeine 0.05 ~ 0.25%, carnitine 0.05 ~ 0.30%, Herba Centellae extract 0.05 ~ 0.30%, the phosphate buffer 0.05 ~ 0.25% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.05 ~ 0.30%;
Component E: essence 0.01 ~ 0.03%.
Preferably, the phosphate buffer of described lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract composition body-building weight-reducing complex, the percentage by weight of described body-building weight-reducing complex is 3% ~ 8%.
Invention applies molecular biology and plant extraction technology, obtain lecithin, caffeine, carnitine, Herba Centellae extract, and Coleus forskohlii Briq. root extract, composition is safe and reliable, by by lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, the phosphate buffer of pH5.7 ~ 8.5, and Coleus forskohlii Briq. root extract carries out reasonable quantized combinations, promote its mutual synergism, make the body-building weight-reducing complex obtained can penetrate into corium and subcutaneous tissue, stimulation collagen and elastin synthesize, stimulate microcirculation, improve lipid metabolism, the fat lobule of prolapsus is effectively impelled to carry out steatolysis effect.
Preferably, by total weight percent meter, each component composition and content are:
Component A: lecithin 1%, Sucrose Polystearic Acid Esters 1.5%, Parleam 5.5%, behenyl alcohol polyethers-25 1.2%, cetearyl alcohol 3%, C15-19 alkane 3%, ring five polydimethylsiloxane 1%, polydimethylsiloxane 1%, Butyrospermum Parkii Oil 2%, tocopherol acetas 0.3%, butylated hydroxytoluene 0.05%;
B component: deionized water 69.07%, ethanol 1.5%, ethylenediaminetetraacetic acid 0.05%, N-acetyl-glucosamine 0.5%, glycerol 4%, butanediol 4%, carbomer 0.5%;
Component C: triethanolamine 0.2%;
D component: DMDM hydantoin 0.1%, iodine propilolic alcohol butyl mephenesin Carbamate 0.02%, caffeine 0.1%, carnitine 0.1%, Herba Centellae extract 0.1%, the phosphate buffer 0.1% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.1%;
Component E: essence 0.01%.
Preferably, by total weight percent meter, each component composition and content are:
Component A: lecithin 1.5%, Sucrose Polystearic Acid Esters 1.5%, Parleam 5.5%, behenyl alcohol polyethers-25 1.2%, cetearyl alcohol 3%, C15-19 alkane 3%, ring five polydimethylsiloxane 1%, polydimethylsiloxane 1%, Butyrospermum Parkii Oil 2%, tocopherol acetas 0.3%, butylated hydroxytoluene 0.05%;
B component: deionized water 69.07%, ethanol 2.5%, ethylenediaminetetraacetic acid 0.05%, N-acetyl-glucosamine 0.5%, glycerol 4%, butanediol 4%, carbomer 0.5%;
Component C: triethanolamine 0.2%;
D component: DMDM hydantoin 0.1%, iodine propilolic alcohol butyl mephenesin Carbamate 0.02%, caffeine 0.2%, carnitine 0.2%, Herba Centellae extract 0.2%, the phosphate buffer 0.2% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.2%;
Component E: essence 0.01%.
Preferably, body-building weight-reducing frost is prepared by following step and obtains:
(1) each for component A composition mix and blend is heated to 70 ~ 80 DEG C;
(2) each for B component composition mix and blend is heated to 75 ~ 85 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 40 ~ 50 DEG C, adding component C, D component and component E, stir, discharging after cooling, obtains body-building weight-reducing frost.
Preferably, body-building weight-reducing frost is prepared by following step and obtains:
(1) each for component A composition mix and blend is heated to 75 DEG C;
(2) each for B component composition mix and blend is heated to 80 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 45 DEG C, adding component C, D component and component E, stir, discharging after cooling, obtains body-building weight-reducing frost.
The composition safety that the present invention utilizes biotechnology technology and plant extraction technology to obtain is good, targeting is good, simultaneously, there is effectively decomposition and be projected into the fat lobule dermal tissue from connective tissue, promote skin metabolism, promote microcirculqtory system effect, stimulation collagen and elastin hypertrophy, effectively active component is transmitted in skin, effectively improves the ripple of tangerine hull constitution, reduce the effect of the aspect such as subcutaneous fat and moist moisturizing skin.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but protection scope of the present invention is not limited to this.
Embodiment 1
A body-building weight-reducing frost, each raw material weight percentage composition is as follows:
Wherein, form body-building weight-reducing complex by the kaliumphosphate buffer of lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract, the addition of described body-building weight-reducing complex is 3%.
Its preparation method comprises the steps:
(1) each for component A composition mix and blend is heated to 75 DEG C;
(2) B component raw material mix and blend is heated to 80 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 45 DEG C, adding C group, D group and E group, stir, discharging after cooling, obtains body-building weight-reducing frost.
Efficacy test:
1. measure lipolytic ability
Method: put human adipose's cell separation in suspension, adds tested product, then utilizes colorimetric enzyme method to measure non-esterified fatty acid;
Testing time: two hours;
Probe temperature: 37 DEG C;
Tested product: 3% body-building weight-reducing complex adds not containing in phenol red MEM substrate, containing penicillin, streptomycin, glutamine, bovine serum albumin fatty acid in substrate;
Contrast groups 1: the substrate not containing body-building weight-reducing complex and adipose cell;
Contrast groups 2: the adipose cell not containing body-building weight-reducing complex and the substrate containing 0.5% ethanol;
Activity determination method: utilize lactate dehydrogenase method for releasing to measure cytotoxicity;
Result shows, compares with the contrast groups 1 not containing body-building weight-reducing complex, contrast groups 2, and the substrate containing body-building weight-reducing complex 3% can make the amount of free fatty (NEFA) increase by 312%, namely substantially increases steatolysis effect.
2. measure fat lobule volume and reduce situation
Tested sample: 20 mean aves be 50 women's testee, all have serious tangerine hull constitution;
Tested product: the mastic containing body-building weight-reducing complex 3%;
Test period: 8 weeks;
Occupation mode: every day uses twice on the tangerine hull constitution of leg portion;
Method of testing: tested before with utilize same way to measure after 8 weeks; Utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result after 8 weeks shows, compared with before the mastic using body-building weight-reducing complex 3%, rear tangerine hull constitution Mian is used to amass the few maximum minimizing 79.5% of 48.92%(of Ping Jun Minus), mean breadth reduces the maximum minimizing 59.1% of 24.12%(), average length/highly reduce the maximum minimizing 57.16% of 35.81%(); Compared with before the mastic using body-building weight-reducing complex 3%, the testee 90% can be observed fat lobule with it and reduce significantly.
Embodiment 2
A body-building weight-reducing frost, each raw material weight percentage composition is as follows:
Wherein, form body-building weight-reducing complex by the kaliumphosphate buffer of lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract, the addition of described body-building weight-reducing complex is 5%.
Its preparation method comprises the steps:
(1) each for component A composition mix and blend is heated to 80 DEG C;
(2) each for B component composition mix and blend is heated to 85 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 50 DEG C, adding C group, D group and E group, stir, discharging after cooling, obtains body-building weight-reducing frost.
Efficacy test:
1. measure lipolytic ability
Method: put human adipose's cell separation in suspension, adds tested product, then utilizes colorimetric enzyme method to measure non-esterified fatty acid;
Testing time: two hours;
Probe temperature: 37 DEG C;
Tested product: 5% body-building weight-reducing complex adds not containing in phenol red MEM substrate, containing penicillin, streptomycin, glutamine, bovine serum albumin fatty acid in substrate;
Contrast groups: the substrate not containing body-building weight-reducing complex and adipose cell;
Contrast groups 2: the adipose cell not containing body-building weight-reducing complex and the substrate containing 0.5% ethanol;
Activity determination method: utilize lactate dehydrogenase method for releasing to measure cytotoxicity;
Result shows, compares with the contrast groups 1 not containing body-building weight-reducing complex, contrast groups 2, and the substrate containing body-building weight-reducing complex 5% can make the amount of free fatty (NEFA) increase by 321%, namely substantially increases steatolysis effect.
2. measure fat lobule volume and reduce situation
Tested sample: 20 mean aves be 50 women's testee, all have serious tangerine hull constitution;
Tested product: the mastic of body-building weight-reducing complex 5%;
Test period: 8 weeks;
Occupation mode: every day uses twice on the tangerine hull constitution of leg portion;
Method of testing: tested before with utilize same way to measure after 8 weeks: utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result shows, compared with before the mastic using body-building weight-reducing complex 5%, rear tangerine hull constitution Mian is used to amass the few maximum minimizing 80.5% of 50.82%(of Ping Jun Minus), mean breadth reduces the maximum minimizing 60% of 25.44%(), average length/highly reduce the maximum minimizing 58.64% of 36.81%(); Compared with before the mastic using body-building weight-reducing complex 5%, the testee 90% can be observed fat lobule with it and reduce significantly.
Embodiment 3
A body-building weight-reducing frost, each raw material weight percentage composition is as follows:
Wherein, form body-building weight-reducing complex by the kaliumphosphate buffer of lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract, the addition of described body-building weight-reducing complex is 5%.
Its preparation method comprises the steps:
(1) component A raw material mix and blend is heated to 70 DEG C;
(2) each for B component composition mix and blend is heated to 75 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 40 DEG C, adding C group, D group and E group, stir, discharging after cooling, obtains body-building weight-reducing frost.
Efficacy test:
1. measure lipolytic ability
Method: put human adipose's cell separation in suspension, adds tested product, then utilizes colorimetric enzyme method to measure non-esterified fatty acid;
Testing time: two hours;
Probe temperature: 37 DEG C;
Tested product: 5% body-building weight-reducing complex adds not containing in phenol red MEM substrate, containing penicillin, streptomycin, glutamine, bovine serum albumin fatty acid in substrate;
Contrast groups 1: the substrate not containing body-building weight-reducing complex and adipose cell;
Contrast groups 2: the adipose cell not containing body-building weight-reducing complex and the substrate containing 0.5% ethanol;
Activity determination method: utilize lactate dehydrogenase method for releasing to measure cytotoxicity;
Result shows, compares with the contrast groups 1 not containing body-building weight-reducing complex, contrast groups 2, and the substrate containing body-building weight-reducing complex 5% can make the amount of free fatty (NEFA) increase by 318%, namely substantially increases steatolysis effect.
2. measure fat lobule volume and reduce situation
Tested sample: 20 mean aves be 50 women's testee, all have serious tangerine hull constitution;
Tested product: the mastic of body-building weight-reducing complex 5%;
Test period: 8 weeks;
Occupation mode: every day uses twice on the tangerine hull constitution of leg portion;
Method of testing: tested before with utilize same way to measure after 8 weeks: utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result after 8 weeks shows, compared with before the mastic using body-building weight-reducing complex 5%, rear tangerine hull constitution Mian is used to amass the few maximum minimizing 81.3% of 51.32%(of Ping Jun Minus), mean breadth reduces the maximum minimizing 60.56% of 26.24%(), average length/highly reduce the maximum minimizing 59.14% of 37.11%(); Compared with before the mastic using body-building weight-reducing complex 5%, the testee 90% can be observed fat lobule with it and reduce significantly.
Embodiment 4
A body-building weight-reducing frost, each raw material weight percentage composition is as follows:
Wherein, form body-building weight-reducing complex by the sodium phosphate buffer of lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract, the addition of described body-building weight-reducing complex is 8%.
Compare with the contrast groups not containing body-building weight-reducing complex, the substrate containing body-building weight-reducing complex 8% can make the amount of free fatty (NEFA) increase by 278%, namely substantially increases steatolysis effect.
Choose women's testee that 20 mean aves are 50, it all has serious tangerine hull constitution; The fat lobule volume measured before and after the mastic using body-building weight-reducing complex 8% reduces situation, test period: 8 weeks, occupation mode: every day uses twice on the tangerine hull constitution of leg portion; Method of testing: utilize same way to measure before tested with after 8 weeks: to utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result after 8 weeks shows, compared with before the mastic using body-building weight-reducing complex 8%, rear tangerine hull constitution Mian is used to amass the few maximum minimizing 77.3% of 47.83%(of Ping Jun Minus), mean breadth reduces the maximum minimizing 56.47% of 22.34%(), average length/highly reduce the maximum minimizing 53.54% of 32.31%(); Compared with before the mastic using body-building weight-reducing complex 8%, the testee 90% can be observed fat lobule with it and reduce significantly.
Embodiment 5
A body-building weight-reducing frost, it comprises component A, B component, component C, D component and component E; By total weight percent meter, each component composition and content are:
Component A: lecithin 1.5%, Sucrose Polystearic Acid Esters 2.5%, Parleam 3.5%, behenyl alcohol polyethers-25 0.5%, cetearyl alcohol 2.0%, C15-19 alkane 2.0%, ring five polydimethylsiloxane 0.5%, polydimethylsiloxane 0.5%, Butyrospermum Parkii Oil 3.0%, tocopherol acetas 0.2%, butylated hydroxytoluene 0.03%;
B component: deionized water 70.35%, ethanol 2.5%, ethylenediaminetetraacetic acid 0.03%, N-acetyl-glucosamine 0.3%, glycerol 5.0%, butanediol 3.0%, carbomer 0.7%;
Component C: triethanolamine 0.3%;
D component: DMDM Hydantoin 0.15%, iodine propilolic alcohol butyl mephenesin Carbamate 0.02%, caffeine 0.15%, carnitine 0.30%, Herba Centellae extract 0.30%, the sodium phosphate buffer 0.15% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.30%;
Component E: essence 0.02%.
It is prepared by following step and obtains:
(1) each for component A composition mix and blend is heated to 75 DEG C;
(2) each for B component composition mix and blend is heated to 80 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 45 DEG C, adding component C, D component and component E, stir, discharging after cooling, obtains body-building weight-reducing frost.
Choose women's testee that 20 mean aves are 50, it all has serious tangerine hull constitution; Measure and use the fat lobule volume before and after body-building weight-reducing frost to reduce situation, test period: 8 weeks, occupation mode: every day uses twice on the tangerine hull constitution of leg portion; Method of testing: utilize same way to measure before tested with after 8 weeks: to utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result after 8 weeks shows, uses rear tangerine hull constitution face to amass the few maximum minimizing 74.31% of 51.24%(of flat equal Minus), mean breadth reduces the maximum minimizing 52.17% of 24.54%(), average length/highly reduce the maximum minimizing 51.12% of 30.73%(); Compared with before use body-building weight-reducing frost, the testee 90% can be observed fat lobule with it and reduce significantly.
Embodiment 6
A kind of body-building weight-reducing compositions, by weight percentage, comprises following component: lecithin 5.5%, ethanol 10%, caffeine 0.5%, carnitine 0.5%, Herba Centellae extract 0.5%, the kaliumphosphate buffer 0.5% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.5%, deionized water 82%.
Choose women's testee that 20 mean aves are 50, it all has serious tangerine hull constitution; Measure and use the fat lobule volume before and after body-building weight-reducing compositions to reduce situation; Test period: 8 weeks, occupation mode: every day uses twice on the tangerine hull constitution of leg portion; Method of testing: utilize same way to measure before tested with after 8 weeks: to utilize 2D-Dermascan ultrasound skin corium skinanalysis apparatus, measure in corium and subcutaneous tissue, the length of prolapsus fat lobule and district's area, to measure the reduction of fat lobule volume.
Test result after 8 weeks shows, compared with before use body-building weight-reducing compositions of the present invention, rear tangerine hull constitution Mian is used to amass the few maximum minimizing 69.1% of 44.67%(of Ping Jun Minus), mean breadth reduces the maximum minimizing 47.63% of 18.34%(), average length/highly reduce the maximum minimizing 47.04% of 23.73%(); Compared with before use body-building weight-reducing compositions of the present invention, the testee 86% can be observed fat lobule with it and reduce significantly.
Claims (6)
1. a body-building weight-reducing compositions, it is characterized in that: by weight percentage, comprise following component: lecithin 0.5 ~ 10%, ethanol 1.0 ~ 20%, caffeine 0.05 ~ 2.0%, carnitine 0.05 ~ 2.0%, Herba Centellae extract 0.05 ~ 2.0%, the phosphate buffer 0.05 ~ 2.0% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.05 ~ 2.0%, deionized water 60 ~ 97.75%; Described phosphate buffer is kaliumphosphate buffer.
2. a body-building weight-reducing frost, is characterized in that: it comprises component A, B component, component C, D component and component E; By total weight percent meter, each component composition and content are:
Component A: lecithin 0.5 ~ 3.0%, Sucrose Polystearic Acid Esters 1.0 ~ 2.5%, Parleam 3.5 ~ 6.5%,
Behenyl alcohol polyethers-25 0.5 ~ 2.0%, cetearyl alcohol 1.5 ~ 3.5%, C15-19 alkane 2.0 ~ 4.0%, ring five polydimethylsiloxane 0.5 ~ 1.5%, polydimethylsiloxane 0.5 ~ 2.0%, Butyrospermum Parkii Oil 1.0 ~ 3.0%, tocopherol acetas 0.1 ~ 0.5%, butylated hydroxytoluene 0.02 ~ 0.07%;
B component: deionized water 52.25 ~ 80.94%, ethanol 1.0 ~ 5.0%, ethylenediaminetetraacetic acid 0.02 ~ 0.07%, N-acetyl-glucosamine 0.2 ~ 1.0%, glycerol 3.0 ~ 5.0%, butanediol 3.0 ~ 5.0%, carbomer 0.3 ~ 1.0%;
Component C: triethanolamine 0.1 ~ 0.4%;
D component: DMDM Hydantoin 0.05 ~ 0.25%, iodine propilolic alcohol butyl mephenesin Carbamate 0.01 ~ 0.03%, caffeine 0.05 ~ 0.25%, carnitine 0.05 ~ 0.30%, Herba Centellae extract 0.05 ~ 0.30%, the phosphate buffer 0.05 ~ 0.25% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.05 ~ 0.30%;
Component E: essence 0.01 ~ 0.03%.
3. body-building weight-reducing frost according to claim 2, it is characterized in that: the phosphate buffer of described lecithin, ethanol, caffeine, carnitine, Herba Centellae extract, pH5.7 ~ 8.5 and Coleus forskohlii Briq. root extract composition body-building weight-reducing complex, the percentage by weight of described body-building weight-reducing complex is 3% ~ 8%.
4. body-building weight-reducing frost according to claim 2, is characterized in that: by total weight percent meter, and each component composition and content are:
Component A: lecithin 1%, Sucrose Polystearic Acid Esters 1.5%, Parleam 5.5%, behenyl alcohol polyethers-25 1.2%, cetearyl alcohol 3%, C15-19 alkane 3%, ring five polydimethylsiloxane 1%, polydimethylsiloxane 1%, Butyrospermum Parkii Oil 2%, tocopherol acetas 0.3%, butylated hydroxytoluene 0.05%;
B component: deionized water 69.07%, ethanol 1.5%, ethylenediaminetetraacetic acid 0.05%, N-acetyl-glucosamine 0.5%, glycerol 4%, butanediol 4%, carbomer 0.5%;
Component C: triethanolamine 0.2%;
D component: DMDM hydantoin 0.1%, iodine propilolic alcohol butyl mephenesin Carbamate 0.02%, caffeine 0.1%, carnitine 0.1%, Herba Centellae extract 0.1%, the phosphate buffer 0.1% of pH5.7 ~ 8.5, Coleus forskohlii Briq. root extract 0.1%;
Component E: essence 0.01%.
5. body-building weight-reducing frost according to claim 2, is characterized in that being prepared by following step and obtaining:
(1) each for component A composition mix and blend is heated to 70 ~ 80 DEG C;
(2) each for B component composition mix and blend is heated to 75 ~ 85 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 40 ~ 50 DEG C, adding component C, D component and component E, stir, discharging after cooling, obtains body-building weight-reducing frost.
6. body-building weight-reducing frost according to claim 2, is characterized in that being prepared by following step and obtaining:
(1) each for component A composition mix and blend is heated to 75 DEG C;
(2) each for B component composition mix and blend is heated to 80 DEG C;
(3), when temperature reaches, B component is joined mix homogeneously in component A and beat homogenizing and obtain mixed phase;
(4) after mixed phase being cooled to 45 DEG C, adding component C, D component and component E, stir, discharging after cooling, obtains body-building weight-reducing frost.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310404808.1A CN103432045B (en) | 2013-09-06 | 2013-09-06 | Body-building and slimming composition and body-building and slimming cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310404808.1A CN103432045B (en) | 2013-09-06 | 2013-09-06 | Body-building and slimming composition and body-building and slimming cream |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103432045A CN103432045A (en) | 2013-12-11 |
| CN103432045B true CN103432045B (en) | 2015-06-24 |
Family
ID=49685833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310404808.1A Active CN103432045B (en) | 2013-09-06 | 2013-09-06 | Body-building and slimming composition and body-building and slimming cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103432045B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104622723A (en) * | 2015-02-06 | 2015-05-20 | 深圳唯美度生物科技有限公司 | Face-thinning BB cream and preparation method thereof |
| CN105796472B (en) * | 2016-03-14 | 2018-10-09 | 杭州百芮生物科技有限公司 | A kind of polynary probiotic composition essence cream and its application |
| CN106265163B (en) * | 2016-08-31 | 2018-02-06 | 伊犁紫苏丽人生物科技有限公司 | A kind of Lavender fat-reducing cream composition |
| CN106619322A (en) * | 2017-02-11 | 2017-05-10 | 佛山市芊茹化妆品有限公司 | Eye masks with function of removing eye bags |
| CN106943324A (en) * | 2017-05-12 | 2017-07-14 | 佛山文森特知识产权服务有限公司 | One kind is dispelled orange peel line cosmetic composition |
| CN110664672A (en) * | 2018-07-02 | 2020-01-10 | 中山市泛华精细化学品有限公司 | Nourishing, moisturizing and repairing cosmetic |
| CN109394622B (en) * | 2018-12-10 | 2021-04-16 | 西安海蓝化妆品有限公司 | Leg slimming essence lotion |
| CN109464452A (en) * | 2018-12-28 | 2019-03-15 | 广州涵夏基因健康科技有限公司 | Application of the adenosine triphosphate salt in preparation external application fat-eliminating slimming product |
| CN111012682A (en) * | 2019-12-23 | 2020-04-17 | 苏州绿叶日用品有限公司 | Slimming nano liposome and preparation method and application thereof |
| CN116370522A (en) * | 2022-12-08 | 2023-07-04 | 青岛优度生物工程有限公司 | Composition for reducing local cellulite, carrier emulsion and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1512889A (en) * | 2001-06-05 | 2004-07-14 | Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite | |
| CN1960698A (en) * | 2004-05-31 | 2007-05-09 | 昭和电工株式会社 | Topical slimming preparation and a cosmetic containing a carnitine derivative |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004217583A (en) * | 2003-01-16 | 2004-08-05 | Naris Cosmetics Co Ltd | Skin care preparation for external use for weight reduction |
-
2013
- 2013-09-06 CN CN201310404808.1A patent/CN103432045B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1512889A (en) * | 2001-06-05 | 2004-07-14 | Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite | |
| CN1960698A (en) * | 2004-05-31 | 2007-05-09 | 昭和电工株式会社 | Topical slimming preparation and a cosmetic containing a carnitine derivative |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103432045A (en) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432045B (en) | Body-building and slimming composition and body-building and slimming cream | |
| CN108652994B (en) | It is a kind of with moisturizing, improve wrinkle and the skin matrix of anti-oxidation efficacy and its preparation method and application | |
| CN101690722B (en) | Composition for slimming | |
| CN103816095A (en) | Deglycation of AGEs | |
| CN106473983A (en) | A kind of moisturizing essence and preparation method thereof | |
| US20130243712A1 (en) | Cosmetic composition for whitening and improving the resilience of skin | |
| CN110302135A (en) | A kind of mild acne eliminating cream | |
| CN108670901B (en) | Skin softening lotion with macadamia nut protein peptide and green tangerine peel extract as active ingredients and preparation method thereof | |
| CN107496316A (en) | A kind of face cream and preparation method thereof | |
| CN115607499B (en) | Ginseng ganoderma lucidum polypeptide composition for resisting wrinkle and compacting and application thereof | |
| CN103479567B (en) | Epidermal growth factor complex liposome and its preparation method and application | |
| CN112587456A (en) | Repairing and whitening composition and preparation method thereof | |
| CN112120949B (en) | Water-light moisturizing essence and preparation method thereof | |
| CN105662966A (en) | Anti-aging plant extract composition | |
| CN108392455A (en) | Face cream and preparation method thereof containing dendrobium candidum extract | |
| CN1777418B (en) | Composition for slimming | |
| CN114159333B (en) | Myobase liquid and preparation method thereof | |
| CN111358710A (en) | Moisture-preserving and soothing donkey-hide gelatin face cream and preparation method thereof | |
| JP2017071568A (en) | Skin external preparation, anti-glycation agent and collagenase inhibitor | |
| CN109646333A (en) | A kind of low deuterium-oxide cosmetics and preparation method thereof | |
| CN115414289A (en) | Cordyceps flower cosmetics and preparation method thereof | |
| CN115089537A (en) | Deep repair essence and preparation method thereof | |
| KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
| EP4288024A1 (en) | Bertholletia excelsa extract and use thereof | |
| CN111743798A (en) | Multi-effect anti-aging skin care product and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171124 Address after: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Chunchao Road No. 93 Patentee after: Yu Xingjun Address before: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Chunchao Road No. 93 Patentee before: YALU BAYER BIOLOGICAL SCIENCE AND TECHNOLOGY (HANGZHOU) CO., LTD. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20171208 Address after: 310000 Sunshine Road No. 688, Chunan County, Chunan County, Hangzhou, 103-4 Patentee after: Only treasure limited company Address before: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Chunchao Road No. 93 Patentee before: Yu Xingjun |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180521 Address after: 311215 spring tide road 93, Qiao Nan block, Xiaoshan economic and Technological Development Zone, Hangzhou, Zhejiang Patentee after: YALU BAYER BIOLOGICAL SCIENCE AND TECHNOLOGY (HANGZHOU) CO., LTD. Address before: 310000 No. 688 Sunshine Road, Thousand Island Lake Town, Chunan County, Hangzhou, Zhejiang, 103-4 Patentee before: Only treasure limited company |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190812 Address after: 313000 First Floor, Building 6, Meichang Kechuang Center, 1616 Pioneer Road, Dixi Town, Wuxing District, Huzhou City, Zhejiang Province Patentee after: Zhejiang Yalu Biotechnology Co., Ltd. Address before: 311215 No. 93 Chunchao Road, Qiaonan District, Xiaoshan Economic and Technological Development Zone, Hangzhou City, Zhejiang Province Patentee before: YALU BAYER BIOLOGICAL SCIENCE AND TECHNOLOGY (HANGZHOU) CO., LTD. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200528 Address after: 311200 floor 5, building 2, ChuanHua Kechuang building, ningwei street, Xiaoshan District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Laizhen Biotechnology Co., Ltd Address before: 313000 First Floor, Building 6, Meichang Kechuang Center, 1616 Pioneer Road, Dixi Town, Wuxing District, Huzhou City, Zhejiang Province Patentee before: Zhejiang Yalu Biotechnology Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220418 Address after: 425000 4th floor, building D, standard workshop of small and medium-sized enterprise entrepreneurship Park, Lengshuitan District, Yongzhou City, Hunan Province Patentee after: Hunan xingboda yaochu Biotechnology Co.,Ltd. Address before: 5 / F, building 2, ChuanHua science and technology building, ningwei street, Xiaoshan District, Hangzhou City, Zhejiang Province, 311200 Patentee before: Zhejiang Laizhen Biotechnology Co.,Ltd. |